Literature DB >> 12738800

Caspase-8 expression and proteolysis in human brain after severe head injury.

Xiaopeng Zhang1, Steven H Graham, Patrick M Kochanek, Donald W Marion, Paula D Nathaniel, Simon C Watkins, Robert S B Clark.   

Abstract

Programmed cell death involves a complex and interrelated cascade of cysteine proteases termed caspases that are synthesized as inactive zymogens, which are proteolytically processed to active enzymes. Caspase-8 is an initiator caspase that becomes activated when Fas death receptor-Fas ligand (FasL) coupling on the cell surface leads to coalescence of a "death complex" perpetuating the programmed cell death cascade. In this study, brain tissue samples removed from adult patients during the surgical management of severe intracranial hypertension after traumatic brain injury (TBI; n=17) were compared with postmortem control brain tissue samples (n=6). Caspase-8 mRNA was measured by semiquantitative reverse transcription and polymerase chain reaction, and caspase-8 protein was examined by Western blot and immunocytochemistry. Fas and FasL were also examined using Western blot. Caspase-8 mRNA and protein were increased in TBI patients vs. controls, and caspase-8 protein was predominately expressed in neurons. Proteolysis of caspase-8 to 20-kDa fragments was seen only in TBI patients. Fas was also increased after TBI vs. control and was associated with relative levels of caspase-8, supporting formation of a death complex. These data identify additional steps in the programmed cell death cascade involving Fas death receptors and caspase-8 after TBI in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738800     DOI: 10.1096/fj.02-1067fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  21 in total

1.  Peroxisome proliferator activated receptor-γ and traumatic brain injury.

Authors:  Lei Qi; Asha Jacob; Ping Wang; Rongqian Wu
Journal:  Int J Clin Exp Med       Date:  2010-09-23

Review 2.  What has inflammation to do with traumatic brain injury?

Authors:  David Cederberg; Peter Siesjö
Journal:  Childs Nerv Syst       Date:  2009-11-26       Impact factor: 1.475

Review 3.  Genetic manipulation of cell death and neuroplasticity pathways in traumatic brain injury.

Authors:  Kathleen M Schoch; Sindhu K Madathil; Kathryn E Saatman
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 4.  Biomarkers in traumatic brain injury.

Authors:  Richa Sharma; Daniel T Laskowitz
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

5.  CSF Bcl-2 and cytochrome C temporal profiles in outcome prediction for adults with severe TBI.

Authors:  Amy K Wagner; Krutika B Amin; Christian Niyonkuru; Brett A Postal; Emily H McCullough; Haishin Ozawa; C Edward Dixon; Hulya Bayir; Robert S Clark; Patrick M Kochanek; Anthony Fabio
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-30       Impact factor: 6.200

6.  Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans.

Authors:  F Anthony Willyerd; Philip E Empey; Ashley Philbrick; Milos D Ikonomovic; Ava M Puccio; Patrick M Kochanek; David O Okonkwo; Robert S B Clark
Journal:  J Neurotrauma       Date:  2015-06-17       Impact factor: 5.269

Review 7.  Caspase-8 as a therapeutic target in cancer.

Authors:  Dwayne G Stupack
Journal:  Cancer Lett       Date:  2010-09-03       Impact factor: 8.679

Review 8.  Apoptosis and traumatic brain injury.

Authors:  Jill Wong; Ng Wai Hoe; Feng Zhiwei; Ivan Ng
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

9.  Mefloquine damage vestibular hair cells in organotypic cultures.

Authors:  Dongzhen Yu; Dalian Ding; Haiyan Jiang; Daniel Stolzberg; Richard Salvi
Journal:  Neurotox Res       Date:  2010-09-22       Impact factor: 3.911

10.  The Fas Ligand/Fas Death Receptor Pathways Contribute to Propofol-Induced Apoptosis and Neuroinflammation in the Brain of Neonatal Rats.

Authors:  Desanka Milanovic; Vesna Pesic; Natasa Loncarevic-Vasiljkovic; Zeljko Pavkovic; Jelena Popic; Selma Kanazir; Vesna Jevtovic-Todorovic; Sabera Ruzdijic
Journal:  Neurotox Res       Date:  2016-05-17       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.